Portfolio Lab

Braveheart Bio, Inc.

  • Stock
  • Ticker BRVE
  • NASDAQ

Braveheart Bio, Inc. has only been trading since 6 Aug 2026. This page shows what the short price history tells, measured from the closing price on the first day with prices. Annualized return, volatility and calendar-year returns follow once a year of prices is available. As of 20 Nov 2026.

First day with prices
6 Aug 2026
Trading days with prices
76
Since the first day with prices
−31.6%
Largest decline
−41.9%
Global equities over the same period
−10.9%

Performance since the first day with prices

BRVEGlobal equities (VT)

$10,000 grew to $6,842. Global equities (VT): $8,907.

Daily values from the closing price on the first day with prices, not from an offer price. Excluding taxes and account costs. Dashed: Global equities (VT) for comparison.

More stocks of similar size

Test BRVE in your own portfolio

Mix it with other securities, set recurring investments and costs, compare against a broad equity ETF. No account needed.

Open in backtest

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.